about
Treatment of dystonia.Seizures and epilepsy: an overview for neuroscientistsNeurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during developmentClinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental studySerotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome.The serotonergic anatomy of the developing human medulla oblongata: implications for pediatric disorders of homeostasisPrevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study.Natural history of succinic semialdehyde dehydrogenase deficiency through adulthoodComparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency'Succinic semialdehyde dehydrogenase deficiency: phenotype evolution in an adolescent patient at 20-year follow-up'.Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.Consideration of gene therapy for paediatric neurotransmitter diseases.Polysomnographic abnormalities in succinic semialdehyde dehydrogenase (SSADH) deficiency.Late infantile neuronal ceroid lipofuscinosis and dopamine deficiency."3 . . 2 . . 1 . . Impact [factor]: target [academic career] destroyed!": just another statistical casualty.Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency.Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene.
P2860
Q30566734-4CC47F2F-48AC-4CBC-B6C3-13DAEE15B70EQ33165796-F8539268-1A1B-494E-81E1-0DC44AB64A15Q33387965-BC5B3061-B821-4F0F-B80D-A63D39A7375AQ34408564-6D7FBB3B-8D44-4535-B148-EBC82BAF93E5Q34880786-ADA9F8DB-7F0F-4265-8F23-FA83FE34A8C7Q35098779-F21B2EEB-AF12-4C83-9B28-0B92C0EB1A3BQ35125526-68B9E58B-5FBE-4EBB-B743-B6F8012A8306Q36027877-E18E2159-BA30-4E2C-82A6-B1419FBDAAFAQ37133507-EFAC84DA-3EBB-4988-BB99-D3ACA5F93530Q37157947-F74BDFA9-B25D-47AA-9E6A-14CDD411C590Q37209217-CDA25A66-4C45-426B-8537-FC452D086162Q37406055-E89BB15A-2B57-4112-81E5-C5D31A3DD6EAQ37449671-32520E24-9BC0-4DBF-BDF3-5A1293C5F804Q48883026-70EA9557-052E-429B-A57B-AB8046862BC0Q50547421-32EF888E-98F2-4A22-B46B-8FE34B05E647Q51543419-4FBAC642-8AAD-48F2-8B23-DB6F3813CA12Q55057734-391028C1-AE84-41F5-B02D-BB2D1FAD0968
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The pediatric neurotransmitter disorders
@ast
The pediatric neurotransmitter disorders
@en
The pediatric neurotransmitter disorders
@nl
type
label
The pediatric neurotransmitter disorders
@ast
The pediatric neurotransmitter disorders
@en
The pediatric neurotransmitter disorders
@nl
prefLabel
The pediatric neurotransmitter disorders
@ast
The pediatric neurotransmitter disorders
@en
The pediatric neurotransmitter disorders
@nl
P2093
P2860
P356
P1476
The pediatric neurotransmitter disorders
@en
P2093
Alex Sokohl
Jacob L Taylor
Phillip L Pearl
Stacey Trzcinski
P2860
P304
P356
10.1177/0883073807302619
P407
P577
2007-05-01T00:00:00Z